Evidence map›Paper›PMID 42511676›Full record

ArticleInternational journal of molecular sciences2026

Extracts from

Chunghyeon Lee, Siyun Lee, Seungju Cho, Sumin Kim, SeonJu Park, Mi Hyeon Cho, Eunji Cho, Jayhyun Park, Hyung-Gwan Lee, Hye Yeon Mun and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Chunghyeon LeeDivision of Biological Science and Technology, Yonsei University, Wonju 26493, Republic of Korea.ORCID 0009-0000-9605-9039
Siyun LeeDivision of Biological Science and Technology, Yonsei University, Wonju 26493, Republic of Korea.ORCID 0009-0005-4336-5389
Seungju ChoDivision of Biological Science and Technology, Yonsei University, Wonju 26493, Republic of Korea.
Sumin KimDivision of Biological Science and Technology, Yonsei University, Wonju 26493, Republic of Korea.
SeonJu ParkMetropolitan Seoul Center, Korea Basic Science Institute (KBSI), Seoul 02841, Republic of Korea.ORCID 0000-0002-0532-5977
Mi Hyeon ChoMetropolitan Seoul Center, Korea Basic Science Institute (KBSI), Seoul 02841, Republic of Korea.
Eunji ChoAnalysis & Evaluation Department, Korea Mine Rehabilitation and Mineral Resources Corporation, Wonju 26464, Republic of Korea.
Jayhyun ParkR&D Team, Korea Mine Rehabilitation and Mineral Resources Corporation, Wonju 26464, Republic of Korea.
Hyung-Gwan LeeCell Factory Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea.
Hye Yeon MunBiological Resources Research Department, Nakdonggang National Institute of Biological Resources, Sangju 37242, Republic of Korea.ORCID 0000-0002-3156-9481
Chang Soo LeeBiological Resources Research Department, Nakdonggang National Institute of Biological Resources, Sangju 37242, Republic of Korea.ORCID 0000-0001-7327-4852
Junsoo ParkDivision of Biological Science and Technology, Yonsei University, Wonju 26493, Republic of Korea.ORCID 0000-0002-2355-6760

Funding

Korea Environmental Industry and Technology Institute RS-2021-KE001783
6 · The paper itself

Abstract

Coronaviruses are responsible for both severe diseases, such as COVID-19, and mild illnesses, such as the common cold. Because coronaviruses are expected to remain continuously prevalent, alternative therapeutic strategies against coronavirus infections should be developed to respond to newly emerging variants. Since many antibiotics, including penicillin, have been isolated from fungi, we screened fungal extracts for antiviral activity against human coronavirus and found that the extract of

Indexed as

Antiviral AgentsCoronavirus OC43, HumanHypocrealesVirus ReplicationAnimalsChlorocebus aethiopsHumansSoil MicrobiologyVero CellsAntiviral AgentsAcremonium inflatumantiviralfungushuman coronavirusValsonectria inflata

Identifiers

PMID42511676
PMCPMC13410906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.